Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients — Stella

Home/Critical Illness/

View on ClinicalTrials.gov

Recruiting

Back to Critical Illness trials

Trial locations(1 site)

China

Shanghai Minhang Central Hospital, Shanghai

Key details

Sponsor

Fudan University

Enrollment target

~45 participants

Started

September 2025

Primary completion

June 2026

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.